Current understanding of Alzheimer’s disease diagnosis and treatment

Cited by (1,000)

Items 701–800 of 1,000

1. Polymeric nanoparticles as drug delivery systems for dementia
   Gerard Esteruelas, Eliana B. Souto, Amanda C. Cano, Miren Ettcheto, Marta Espina, Antoni Camins, Maria Luisa García, Elena Sánchez‐López · 2022 · Elsevier eBooks
2. Alzheimer hastalığı klinik ölçütlerine göre demans ve hafif kognitif bozukluk ayrımında sözel akıcılık testlerinin mini mental durum testi ile birlikte kullanılması yararlı olabilir
   Didem Öz, Yağmur Özbek, İlayda Kıyı, Görsev Yener · 2022 · Çukurova medical journal (Online)/Çukurova medical journal
3. The influence of gut brain axis in neurodegenerative diseases: short review
   Renata Murguiondo Pérez, Oscar Alcantar-Garibay, Efraín Weintraub Ben-Zión, Enrique Blancarte-Hernández, Emilio Tejerina Marion, Ericka Cristina Loza-López, Mario Galindo-Ruiz, Germán Rivera Monroy · 2022 · Revista de Fomento Social
4. Identifying sex-specific risk architectures for predicting amyloid deposition using neural networks
   Linghai Wang, Antonija Kolobaric, Howard Jay Aizenstein, Brian J. Lopresti, Dana Tudorascu, Beth Ellen Snitz, William Edward Klunk, Minjie Wu · 2023 · NeuroImage
5. Synthesis of Chiral Tricyclic Pyrone Molecules via Palladium(0)‐Catalyzed Displacement Reactions of Chiral Tricyclic Pyrone Acetate With Azide or Amine
   Shunya Morita, Zhaoyang Ren, Huafang Fan, Duy H. Hua · 2023 · ChemistrySelect
6. Retinal inner nuclear layer thickness in the diagnosis of cognitive impairment explored using a C57BL/6J mouse model
   Jack Jonathan Maran, Moradeke M. Adesina, Colin Richard Green, Andrea Kwakowsky, Odunayo Omolola Mugisho · 2023 · Scientific Reports
7. Radiomics for Alzheimer’s Disease: Fundamental Principles and Clinical Applications
   Eleni Georgiadou, Haralabos Bougias, Stephanos Leandrou, Nikolaos Stogiannos · 2023 · Advances in experimental medicine and biology
8. Named Entity Recognition and Normalization for Alzheimer’s Disease Eligibility Criteria
   Zenan Sun, Cui Tao · 2023 · IEEE International Conference on Healthcare Informatics (ICHI)
9. Decreased short-latency afferent inhibition in individuals with mild cognitive impairment: A TMS-EEG study
   Yu Mimura, Yui Tobari, Shinichiro Nakajima, Mayuko Takano, Masataka Wada, Shiori Honda, Shogyoku Bun, Hajime Tabuchi, Daisuke Ito, Mié Matsui et al. · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
10. A New Cell Model Overexpressing sTGFBR3 for Studying Alzheimer's Disease In vitro
    Jiangxia Chen, Lijun Zhou, Qingchun Zhao, Zhentong Qi · 2024 · Current Pharmaceutical Design
11. Doença de Alzheimer: tratamento através do sistema único de saúde
    Letícia Fogaça Mendes · 2024 · Arquivos de Saúde do UniSantaCruz
12. Text mining and portal development for gene-specific publications on Alzheimer’s disease and other neurodegenerative diseases
    Jiannan Liu, Huanmei Wu, D. H. Robertson, Jie Zhang · 2024 · BMC Medical Informatics and Decision Making
13. Association of MME gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population
    Fereshteh Khalili-Moghadam, Javad Hosseini Nejad, Taleb Badri, Morteza Sadeghi, Javad Gharechahi · 2024 · Heliyon
14. NAD+ Boosting Strategies
    Jared Rice, Sofie Lautrup, Evandro Fei Fang · 2024 · Sub-cellular biochemistry/Subcellular biochemistry
15. Autoimmune diseases and microbiome targeted therapies
    Preeti Jain, Nitika Joshi, Vishal Sahu, Abishai Dominic, Sadhna Aggarwal · 2025 · International review of cytology
16. From ambiguity to accuracy: A review of Alzheimer’s disease diagnostic errors and the need for non-invasive biomarkers
    Deepthi Rapaka, Arthur Saniotis, Kazhaleh Mohammadi, Francesco Maria Galassi, Paramasivan O. Kumar, Veera Raghavulu Bitra · 2025 · Journal of Neurosciences in Rural Practice
17. Identification of significant protein in protein-protein interaction of Alzheimer disease using top-k representative skyline query
    Mohammad Romano Diansyah, Wisnu Ananta Kusuma, Annisa Annisa · 2021 · Jurnal Teknologi dan Sistem Komputer
18. Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease
    Kavita Patel, Siwangi Srivastava, Shikha Kushwah, Ashutosh Mani · 2021 · Journal of Alzheimer s Disease Reports
19. Intelligent Algorithm-Based Quantitative Electroencephalography in Evaluating Cerebral Small Vessel Disease Complicated by Cognitive Impairment
    Hengya Zhu, Jingjing Qiu, Xiaoyan Sun, Yang Xiang-yan, Bin Zhang, Ying Tan · 2022 · Computational and Mathematical Methods in Medicine · Retracted
20. Exploring Early Physical Examination Diagnostic Biomarkers for Alzheimer’s Disease Based on Least Absolute Shrinkage and Selection Operator
    Hua Lin, Shiting Tang, Ling Liang, Liechun Chen, Chun Zou, Donghua Zou · 2022 · Computational and Mathematical Methods in Medicine · Retracted
21. Early Diagnosis of Alzheimer's Disease Using Hybrid Word Embedding and Linguistic Characteristics
    Yangyang Li · 2020 · International Conference on Algorithms, Computing and Artificial Intelligence (ACAI)
22. Detecting Cognitive Decline in Early Alzheimer’s Patients Using Wearable Technologies
    Eaman Alharbi, Akram Alomainy, Janelle M. Jones · 2020 · IEEE International Conference on Healthcare Informatics (ICHI)
23. Uma abordagem geral da demência: Doença de Alzheimer e Demência Vascular
    Maria Eduarda Marini Amante Gomide, Carlos Eduardo Reis Souza de Oliveira Pereira, Thiago Mendes dos Santos, Luísa Miranda Braga Lopes, Clarissa Vasconcellos Soares, Maria Clara Neves Wagner, Isabelle de Moraes Amorim, Ana Clara Gê Pinto Ribeiro, Ana Paula Miranda, Hélcio Serpa de Figueiredo Júnior · 2022 · Revista Eletrônica Acervo Médico
24. Presymptomatic Diagnosis and Gene Therapy for Alzheimer’s Disease: Genomic, Therapeutic, and Ethical Aspects—A Systematic Review
    Théodora Mahoukèdè Zohoncon, Joseph Sawadogo, Abdoul Karim Ouattara, Abdou Azaque Zouré, Marie N. L. Ouedraogo, Paul Ouédraogo, Florencia Wendkuuni Djigma, Christelle Nadembega, Raphael Kabore, Djénèba Ouermi et al. · 2023 · Advances in Alzheimer s Disease
25. Curcuma longa L. (Zingiberaceae): desenvolvimento tecnológico para aplicação como agente terapêutico auxiliar no tratamento de pacientes portadores da Doença de Alzheimer
    Ayla Winnie Ramos da Silva, Renata Biegelmeyer · 2020 · Revista Fitos
26. Effects of genetic liability to Alzheimer’s disease on circulating metabolites across the life course
    Hannah Compton, Madeleine L. Smith, Caroline J. Bull, Roxanna Korologou‐Linden, Yoav Ben‐Shlomo, Joshua A. Bell, Emma Louise Anderson · 2022 · medRxiv
27. Advanced Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases
    Rafaela Ferrão, Akhilesh Rai · 2024 · Wiley eBooks
28. Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer’s disease brain tissue
    Bernardo Aguzzoli Heberle, Kristin L. Fox, Lucas Lobraico Libermann, Sophia Ronchetti Martins Xavier, Guilherme Tarnowski Dallarosa, Rhaná Carolina Santos, David W. Fardo, Thiago Wendt Viola, Mark Ebbert · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
29. Decoding the diagnostic potential of T cell repertoires in peripheral blood of patients from amnestic mild cognitive impairment to Alzheimer's disease
    Yansheng Du, Yichen Zhang, Jiuzhou Diao, Pengrui Fu, Runze Jiang, Ping Wang, Hui Yang, Xiaolei Zheng, Leisheng Zhang, Jianzhong Bi et al. · 2023 · The FASEB Journal
30. The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis
    Wenting Zhang, G.X. Zhang, Shuaishuai Gao · 2024 · Neurología (English Edition)
31. Cordia dichotoma G. Forst fruit prophylactic against Alzheimer's risk factors: in vitro study
    Faten Mohamed Ibrahim, Abeer Yousry Ibrahim, Heba Mostafa Amer, Mohamed Fawzy Ramadan, Reda Sayed Mohammed · 2024 · RENDICONTI LINCEI
32. The causal role of lipids in dementia: A Mendelian randomization study
    Boyang Su, Zhengqing He, Li Mao, Xusheng Huang · 2025 · Journal of Alzheimer s Disease Reports
33. Assessing Public Awareness of Neuropsychiatric and Cognitive Symptoms of Alzheimer’s Disease in the Eastern Region of Saudi Arabia: A Cross-sectional Study
    Maryam Alnaim, Wasayf M. Al Shanabah, Lujain Alhashmi Alamer, Waad Abdulelah Alduraywish, Munirah Alkhitrish, Wesam Alshuaibi, Sarah Anwar Almulla, Latifah Abdullah A Almulhim, Hamad A. Al Sagoor, Alia Ali Alokley · 2025 · Annals of African Medicine
34. Acceleration-Dependent Effects of Vibrotactile Gamma Stimulation on Cognitive Recovery and Cholinergic Function in a Scopolamine-Induced Neurotoxicity Mouse Model
    Taewoo Kim, Hee‐Jung Park, Myeong-Hyun Nam, In-Ho Lee, Zu-Yu Chen, Hee-Deok Yun, Young‐Kwon Seo · 2025 · Biomedicines
35. What is known from the existing literature about adolescent knowledge and attitudes towards dementia and interventions to enhance this? A scoping review
    Niamh McCarthy, Svea Nagel, Gabriel Vaughan, Emma Berry, Gillian Carter, Lisa Graham‐Wisener · 2025 · PLoS ONE
36. Pharmacological mechanisms and therapeutic prospects of plant metabolites from traditional Chinese medicine in regulating programmed cell death in Alzheimer’s disease
    Pengyu Pan, Tengyu Zhao, Jian Zhang, Yuhan Zhou, Xinyue Zhang, Quan Li, Yanyan Zhou · 2025 · Frontiers in Pharmacology
37. The impact of high-intensity interval training on cerebrovascular function in the APP/PS1 mice
    Lei Zhu, Ming Cai, Zhe Lu, Qi Wang, Teng Zhai, Jingyun Hu · 2025 · Frontiers in Aging
38. Uncovering the cytophenotypic and transcriptomic features of natural killer cells derived from peripheral blood of patients with Alzheimer's disease
    Hui Yang, Xingjie You, Caibin Yue, Xiao Yu, Xinyi Yue, Xiaolei Zheng, Xuankai Yan, Jiatong Li, Jianzhong Bi, Leisheng Zhang et al. · 2025 · Journal of Alzheimer s Disease
39. Intranasal delivery of therapeutics to degenerating brain regions: From pathways to nanocarriers
    Parasmita Saha, Sayon J. Roy, Srijan Bhattacharya, Aparna Datta · 2025 · Journal of Drug Delivery Science and Technology
40. The Vitamin D Receptor Ortholog Hr96 Modulates Neuronal and Mitochondrial Dynamics in a Drosophila Model of Alzheimer’s Disease
    Guilherme Gischkow Rucatti, Francisco Muñoz-Carvajal, Nicole Sanhueza, Sebastián Oyarce-Pezoa, Yesid Cuesta-Astroz, Leandro Murgas Saavedra, Melissa Caru-Ruiz, Alberto J. M. Martín, Melissa Nassif, Carol D. SanMartín et al. · 2025 · Molecular Neurobiology
41. Discovery and Identification of Bioactive Organic Compounds From Callistemon citrinus (Bottlebrush) as Natural Inhibitors of Acetylcholinesterase (AChE) Enzyme via the Cholinergic Pathway for the Management of Alzheimer's Disease
    Devesh Singh Baral, Rakesh Verma · 2025 · ChemistrySelect
42. Non-invasive screening of alzheimer’s disease via label-free tri-spectral retinal imaging
    Zita Salajková, Gabriele Ciasca, Francesco Di Lorenzo, Maryamsadat Ghoreishi, Riccardo Reale, Maria Grazia Gambarota, Jianping Zhang, Yanxing Zhang, Vincenzo Ricco, Giancarlo Ruocco et al. · 2026 · Scientific Reports
43. Network analysis of optimal deep or machine learning strategies for classification and detection of Alzheimer’s disease based on MRI scanning
    Qinyu Zhang, Luping Ma, Lulei Zhao, Shaofeng Zhu, Hongyang Qi, Zhenzhen Pan, Jie Zhou · 2026 · Frontiers in Neuroscience
44. A Global Review on Alzheimer’s Disease
    Natarajan. P, P Mumthaj., Vijay. J, V Gokul. · 2021 · International Journal of Pharmaceutical Sciences Review and Research
45. Structural study of the recognition mechanism of tau antibody Tau2r3 with the key sequence (VQIINK) in tau aggregation
    Tomohiro Tsuchida, Kouki Susa, Tomohiro Kibiki, Takahiro Tsuchiya, Katsushiro Miyamoto, Yasuko In, Katsuhiko Minoura, Taizo Taniguchi, Toshimasa Ishida, Koji Tomoo · 2021 · Biochemical and Biophysical Research Communications
46. A Review on the Correlation between the Pathology of Alzheimer's Disease and microRNA
    Soo-Jung Kim, Hyunjeong Cho · 2021 · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters
47. Clinical features of dementia cases ascertained by ICD coding in LIMBIC-CENC multicenter study of mild traumatic brain injury
    William C. Walker, Justin J. F. O’Rourke, Elisabeth A. Wilde, Mary Jo Pugh, Kimbra Kenney, Clara Dismuke, Zhining Ou, Angela P. Presson, J. Kent Werner, Jacob T. Kean et al. · 2022 · Brain Injury
48. TAU IMMUNOTHERAPY FOR ALZHEIMER’S (Review Article)
    Abivarma Chandrakumaran, Ashwin Achuthaprasad, PAK DANIEL, JOEL JACOB · 2022 · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA
49. Heme/Cu-oxygen intermediates of amyloid β peptides associated with Alzheimer's disease
    Madhuparna Roy, Somdatta Ghosh Dey · 2022 · Advances in inorganic chemistry
50. Dementia: A journey from cause to cure
    Shilpa Kumari, Kajal Bagri, Rahul R Deshmukh · 2022 · Elsevier eBooks
51. ALUMINIUM AND FLUORINE IN DRINKING WATER AS RISK FACTORS FOR HUMAN HEALTH
    Fatma Özsel Özcan Araç, Ozan Aldemir · 2022 · GIDA / THE JOURNAL OF FOOD
52. Life Experience Matters: Enrichment and Stress Can Influence the Likelihood of Developing Alzheimer’s Disease via Gut Microbiome
    Sarah E. Torraville, Cassandra M. Flynn, Tori L. Kendall, Qi Yuan · 2023 · Biomedicines
53. Classification of Mild Cognitive Impairment with Deep Transfer Learning Approach using CWT based Scalogram Images
    P. Saroja, N. J. Nalini, Gadiraju Mahesh · 2023 · International Journal on Recent and Innovation Trends in Computing and Communication
54. Role of Endogenous and Dietary Antioxidants in Brain Disorders
    Rabia Akram, Humaira Muzaffar, Haseeb Anwar, Shoaib Ahmad Malik, Faiqa Sajid, Tehreem Iman, Ayesha Ahsan, Mobina Manzoor, Ikram Ullah Khan, Ghulam Hussain · 2023 · Food bioactive ingredients
55. Racial differences in the effect of APOE‐ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study
    Chun Di Xu, Priscila Acevedo, Yongke Lu, Bin Su, Kaysie Ozuna, Victoria Padilla, Annu Karithara, Chunxiang Mao, Ramiro Osvaldo Navia, Ubolrat Piamjariyakul et al. · 2023 · International Journal of Geriatric Psychiatry
56. Effects of extracts and manna of Echinops cephalotes on impaired cognitive function induced by scopolamine in mice
    Giti Sadeghi, Masoud Sadeghi Dinani, Mohammad Rabbani · 2024 · Research in Pharmaceutical Sciences
57. Liquid clues: tear film biomarkers unravelling Alzheimer’s mysteries
    Amna Zaheer, Insa Binte Anwar, Abdul Haseeb, Alisha Yadav · 2024 · Annals of Medicine and Surgery
58. ALZHEIMER HASTALIĞI, RİSK FAKTÖRLERİ VE TEDAVİ
    Nejla Yıldırım, Benay Can Eke · 2024 · Ankara Universitesi Eczacilik Fakultesi Dergisi
59. Associations of Plasma Glutamatergic Metabolites with Alpha Desynchronization during Cognitive Interference and Working Memory Tasks in Asymptomatic Alzheimer’s Disease
    Vincent Leong, Jiaquan Yu, Katherine Castor, Abdulhakim Abdullah A Al‐Ezzi, Xianghong Arakaki, Alfred Nji Fonteh · 2024 · Cells
60. Neuroprotective effects of Elaeagnus glabra f. oxyphylla extract in amyloid-beta-induced cognitive deficit mice: Involvement of the PKC-delta, MYL2, and FER pathways
    Eunjin Sohn, Hye-Sun Lim, Bu‐Yeo Kim, Yu Jin Kim, Joo‐Hwan Kim, Soo‐Jin Jeong · 2024 · Biomedicine & Pharmacotherapy
61. Varenicline Attenuates Memory Impairment in Amyloid-Beta-Induced Rat Model of Alzheimer’s Disease
    Seyed Zanyar Athari, Sareh Kazmi, Seyed Mehdi Vatandoust, Javad Mahmoudi, Fereshteh Farajdokht, Fatemeh Hajihosseinlou, Pedram Ghaderi, Alireza Majdi, Saeed Sadigh‐Eteghad · 2025 · Neurochemical Research
62. Utilizing Functionalized Dual-Microbead Interfaces for Measurements of Amyloid-beta (1–42) with Femtomolar Sensitivity
    Jennifer M. Pollock, Connor H. Yew, Anubhav Tripathi · 2025 · Langmuir
63. Federated Multi-source Domain Adaptation via Vision Transformer for Multi-site Alzheimer’s Diagnosis
    Tuo Cai, Baiying Lei, Xueqin Yan, Cuimei Wei, Chunhua Liang, Xiaohua Xiao, Yunzhu Yang, Tianfu Wang, Peng Yang · 2025 · Lecture notes in computer science
64. Polymer Nanogels with Albumin Reporting Interface Created Using RAFT Precipitation Polymerization for Disease Diagnosis and Food Testing
    Yukiya Kitayama, Erika Yoshimatsu, Atsushi Harada · 2025 · Advanced Materials Interfaces
65. Alzheimer’s Disease in the Age of Precision Medicine: Advances in Pathophysiology, Clinical Management and Therapeutic Strategies
    Michał Piotrowski, Piotr Serwicki, Szczepan Pośpiech, Jakub Prosowski, Jakub Początek, Jessika Schendzielorz · 2025 · Quality in Sport
66. The Two-Stage Alzheimer’s Disease Automatic Diagnosis Algorithm Based on ST-MBV3 Model
    Guiping Li, Zhenhao Jin, Minghui Deng, Junjie Gong, Piaoyi Zheng · 2025 · International Journal of Computational Intelligence Systems
67. Neuropharmacological activities of Eclipta alba (L.) Hassk. in the context of Alzheimer's and Parkinson's diseases: A mini review
    Abir Biswas, R G Abirami, Anitha Rathinam, Kesavan Swaminathan Jayachandran, Muthuswamy Anusuyadevi · 2025 · Pharmacological Research - Natural Products
68. Regulation of Caenorhabditis Elegans model in Alzheimer’s Disease
    Yuxuan Jing · 2020 · E3S Web of Conferences
69. OUP accepted manuscript
    Vincent Henry, Ivan Moszer, Olivier Dameron, Laura Xicota, Bruno Dubois, Marie‐Claude Potier, Martin Hofmann‐Apitius, Olivier Colliot · 2021 · Database
70. Enhancing Alzheimer’s Disease Diagnosis via Hierarchical 3D-FCN with Multi-Modal Features
    Chao Liu, Xiaodong Yang, Dading Chong, Wenwu Wang, Liang Li · 2021 · Proceedings - International Conference on Image Processing
71. Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study
    Hallie Morton, Tanisha Basu, Chhanda Bose, P. Hemachandra Reddy · 2022 · Journal of Alzheimer s Disease
72. Nanoceuticals as Theranostics Against Neurodegenerative Diseases
    Prabhakar Mishra, Santosh Anand · 2022 · Nutritional neurosciences
73. Silibinin Improves the Clinical Scores of Memory Function in Patients with Mild Cognitive Impairment: A Double-Blind, Placebo-Controlled Pilot Study
    Saad Abdulrahman Hussain, Zainab Saad Abdulrahman, Wael Waleed Mustafa · 2022 · Biomedical & Pharmacology Journal
74. Cost-effectiveness of a gene sequencing test for Alzheimer’s disease in Ontario
    Nicolas Iragorri, Danielle Toccalino, Sujata Mishra, Brian Chan, Allison Ann Dilliott, John F. Robinson, Robert Alexander Hegele, Rebecca Hancock, The ONDRI Investigators · 2022 · Journal of Community Genetics
75. Neuroprotekcyjne działanie kurkuminy i jej potencjalne zastosowanie w leczeniu chorób neurodegeneracyjnych
    Mikołaj Górka, Natalia Białoń, Dominika Bieczek, Dariusz Górka · 2023 · Postępy Biochemii
76. Nanomicelles of taurine inhibit the fibrillation and toxicity of amyloid β1-42 peptide
    Natália Cristina Gomes-da-Silva, Marília Amável Gomes Soares, Eduardo Ricci‐Júnior, Maria do Socorro do Nascimento Amorim, Luciana Magalhães Rebêlo Alencar, Prapanna Bhattarai, Lin Zhu, Cristian Follmer, Ralph Santos‐Oliveira · 2023 · Journal of Drug Delivery Science and Technology
77. Molecular Docking of Fisetin as a Multi-target drug in the treatment of Alzheimer’s disease
    Malathi R, Vailina Dsouza, Puja Puja, R. Rithika, P. Sneha · 2023 · Research Journal of Pharmacy and Technology
78. The protective effects of Chromofungin in oligomeric amyloid β42 (Aβ42)-induced toxicity in neurons in Alzheimer’s disease
    Qingwei Li, Ji Sun, Qin Ran, Ziming Liu, Jinmei Chen · 2024 · Aging
79. Data Science Techniques to Support Prediction, Diagnosis and Recode Treatment of Alzheimer'S Disease
    Matthew Harper, Jamila Mustafina, Ahmed J. Aljaaf, Jan Lunn, Salwa Yasen, Fawaz Ghali · 2019 · International Conference on Developments in eSystems Engineering (DeSE)
80. Role of the gut microbiota in human health
    Aleksandra Chałupnik, Zuzanna Chilimoniuk, Anna Sobstyl, Maciej Dobosz, Aleksandra Borkowska, Małgorzata Wieteska · 2020 · Journal of Education Health and Sport
81. The Potential Role of Naproxen in Promoting Rivastigmine Effect Against Aluminum Chloride-Induced Alzheimer-Like Model in Rats
    Raafat A. Abdel‐Aal, Ola A. Hussein, Reham G. Elsaady, Lobna A. Abdelzaher · 2021 · Research Square
82. Manipulation of neuronal activity in the entorhinal-hippocampal circuit affects intraneuronal amyloid-β levels
    Christiana Bjorkli, Nora Cecilie Ebbesen, Joshua B. Julian, Menno P. Witter, Axel Sandvig, Ioanna Sandvig · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
83. Prevalence and risk factors of non-communicable diseases in indigenous populations of South Asia: a systematic review protocol
    Sajda Khatoon, Paramita Bhattacharya, Nirmalya Mukherjee, Jaideep Chanavil Menon, Chandrashekar Janakiram, Ambigai Rajendran, Pritha Das, Denny John · 2023 · Research Square
84. Association between a computerized, Self-administered cognitive assessment and phosphorylated Tau in Alzheimer’s Disease
    Mina Aghaei, Zahra Vahabi, Mohammad Hadi Modarres, Fatemeh Ebrahiminia, Seyed‐Mahdi Khaligh‐Razavi · 2024 · medRxiv
85. OBSERVAÇÃO DOS CASOS DE INTERNAÇÕES POR DOENÇA DE ALZHEIMER DE 2014 A 2019
    Bryan Morais, Felipe Teixeira Freitas, Fagner Bastos Dutra, YOAN GOMES FREITAS CARDOSO, Victor Fellipe Justiniano Barbosa · 2022 · Revista Ibero-Americana de Humanidades, Ciências e Educação
86. Applications of Nanotechnology in Alzheimer’s Disease
    Maria Chountoulesi, Nikolaos Naziris, Anna Gioran, Aristeidis Papagiannopoulos, Barry R. Steele, Maria Micha‐Screttas, Stavros G. Stavrinides, Michael P. Hanias, Niki Chondrogianni, Stergios Pispas et al. · 2023 · Springer eBooks
87. Cognitive Impairment Detection System based on Image Segmentation and Artificial Intelligence Art
    Yuqi Zhang, Qingwei Song, Takenori Obo, Naoyuki Kubota · 2023 · Communications in computer and information science
88. Protective effects of Protaetia brevitarsis larvae against memory impairment in scopolamine-induced mice
    Ji Myung Choi, Mi So Cho, Byeong Wook Noh, Eun Ju Cho, Ji Hyun Kim, Hyun Young Kim · 2024 · Journal of Applied Biological Chemistry
89. Angiotensin Converting Enzyme-2 (ACE-2): A Target for Novel Drug Development
    Mit Joshi, Ramesh Kishorilal Goyal, Bhoomika M. Patel · 2024 · Advances in biochemistry in health and disease
90. Cerebral perfusion alterations in healthy young adults due to two genetic risk factors of Alzheimer’s disease: APOE and MAPT
    Samuel K. Bennett, Jianmin Zeng, Maria‐Eleni Dounavi, Arshad Majid, Sheharyar Sajjad Baig, Matteo De Marco, Craig William Ritchie, John Tiernan O'Brien, Li Su · 2025 · Journal of Cerebral Blood Flow & Metabolism
91. Advancements in Alzheimer’s Disease Biomarkers: Emerging Protein Targets for Early Diagnosis and Therapeutic Intervention
    Mst Muslima Khatun, MO Oni, Md. Shadin, B S M Bodiuzzaman · 2025 · Journal of Medicinal Chemistry and Therapeutics
92. Assessing Motor Cortex Excitability and Its Relationship with Cortical Atrophy in Alzheimer’s Dementia
    Renee P Lawson, Reza Zomorrodi, Michael J. E. Joseph, Hiba Alhabbal, Gifty Asare, Daniel M. Blumberger, Zafiris Jeff Daskalakis, Corinne Eleanor Fischer, Benoit H. Mulsant, Bruce G. Pollock et al. · 2025 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
93. Targeting Fyn Kinase for Alleviation of Cognitive Impairment in Streptozocin-Induced Alzheimer’s Disease in Mice by Loperamide; An Experimental and in Silico Analysis
    Halima Qadir, Syed Haroon Hussain, Amama Ghaffar, Fawad Ali Shah, Sagheer Ahmed · 2025 · Neurochemical Research
94. Cerebrospinal Fluid Biomarkers of Alzheimer Disease
    Невзорова Ксения Васильевна, Yu. A. Shpilyukova, Алла Анатольевна Шабалина, E. Yu. Fedotova, Sergey Nikolaevich Illarioshkin · 2025 · Annals of Clinical and Experimental Neurology
95. Unveiling the Therapeutic Potential of Piper chaba Hunter: Computational Approaches Shed Light on Targeting Proteins in Alzheimer’s Disease
    Md. Sifat Rahi, Md. Shahedur Rahman, Rima Islam Meem, Md. Ebrahim Khalil Shimul, Nahid Farnaj, Md. Humaun Kabir, Fee Faysal Ahmed, Md. Anowar Khasru Parvez, Md. Amdadul Huq, Tabassum Kabir et al. · 2025 · BioMed Research International
96. Identification of Druggable Targets for Alzheimer's Disease by Analyzing Circulating Inflammatory Proteins With Mendelian Randomization
    Hongliang An, Jianhong Gu, Taiping Li · 2025 · Brain and Behavior
97. Investigating the Effect of Human APOE Gene on Mitochondrial Dynamics of Nervous System Cells in Drosophila Models of Alzheimer’s Disease
    Asma Mirkamali, Samaneh Reiszadeh Jahromi · 2025 · Russian Journal of Genetics
98. A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits
    Yuan Zhou, Ting Su, Mei Yuan, Wenlian Li, Yang Zhou, Jiaxin Kou, Jia-Sheng Chang, Dan Liu, Lin Chen, Ke‐Bin Zhan et al. · 2025 · Journal of Alzheimer s Disease
99. An appraisal on biomolecular imaging in diagnosis of neurological disorders and innovation in clinical research
    Deepti Katiyar, Manish Manish · 2025 · Letters in Drug Design & Discovery
100. Exploring self-nanoemulsifying drug delivery system (SNEDDS) in combating neurodegeneration: a revolutionary tool for drug targeting in Alzheimer’s and Parkinson’s disease
     Shivani Tyagi, Jayendra Kumar, Shobhit Kumar · 2025 · Journal of Dispersion Science and Technology